Stratec's switch to own products hits prosthetics sales
This article was originally published in Clinica
Executive Summary
Sales in Stratec's prosthetics division have been hit as the company tries to implement its own manufacturing and marketing structure for these products. Sales of the Swiss company's prosthetic goods fell 27% to SwFr26.6 million ($18 million) in the first half of 1998.